STOCKHOLDERS’ EQUITY (Details Narrative) | | | | | | | | | | | | | | | | | 1 Months Ended | 12 Months Ended | | |
Oct. 16, 2023 USD ($) $ / shares shares | Sep. 21, 2023 shares | Sep. 20, 2023 USD ($) $ / shares shares | Sep. 02, 2023 USD ($) $ / shares shares | Aug. 15, 2023 USD ($) $ / shares shares | Jul. 20, 2023 USD ($) $ / shares shares | Jul. 11, 2023 USD ($) $ / shares shares | Jul. 10, 2023 USD ($) $ / shares shares | Jun. 30, 2023 USD ($) $ / shares shares | Jun. 23, 2023 USD ($) $ / shares shares | May 02, 2023 USD ($) $ / shares shares | May 01, 2023 USD ($) $ / shares shares | Apr. 20, 2023 USD ($) $ / shares shares | Oct. 17, 2022 $ / shares shares | Jul. 11, 2022 USD ($) $ / shares shares | Jul. 11, 2022 USD ($) $ / shares | Apr. 28, 2022 USD ($) $ / shares shares | Apr. 30, 2023 USD ($) $ / shares shares | Dec. 31, 2022 USD ($) $ / shares shares | Jan. 31, 2022 USD ($) $ / shares shares | Oct. 31, 2023 USD ($) $ / shares shares | Oct. 31, 2022 USD ($) $ / shares shares | Jan. 28, 2022 USD ($) $ / shares | Oct. 31, 2021 $ / shares |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Aggregate authorized shares | shares | | | | | | | | | | | | | | | | | | | | | 500,000,000 | | | |
Common stock, shares authorized | shares | | | | | | | | | | | | | | | | | | | | | 490,000,000 | 490,000,000 | | |
Common stock, par value | $ / shares | | | | | | | | | | | | | | | | | | | | | $ 0.0001 | $ 0.0001 | | |
Preferred stock, shares authorized | shares | | | | | | | | | | | | | | | | | | | | | 10,000,000 | 10,000,000 | | |
Preferred stock, par value | $ / shares | | | | | | | | | | | | | | | | | | | | | $ 0.0001 | $ 0.0001 | | |
Share price | $ / shares | $ 0.27 | | | | | | | | | | | | | | | | | | | | | | | |
Grant date value | | | | | | | | | | | | | | | | | | | | | $ 372,000 | $ 60,000 | | |
Stock based compensation | | | | | | | | | | | | | | | | | | | | | 1,044,261 | 6,202 | | |
Share based compensation, unrecognized expense | | | | | | | | | | | | | | | | | | | | | 267,659 | | | |
Gross proceeds | | | | | | | | | | | | | | | | | | | | | 738,659 | 60,543 | | |
Stock issued value during period for services | | | | | | | | | | | | | | | | | | | | | 366,659 | | | |
Resale amendment agreement, description | | | | | | | | | the Company issued a Form S-1/A, which registered for resale (i) up to 3,149,314 shares of common stock, par value $0.0001 per share which the selling stockholders may acquire upon the exercise of outstanding common warrants and (ii) up to 500,000 shares of common stock, which the selling stockholders may acquire upon the exercise of outstanding pre-funded warrants. Such warrants were issued to the selling stockholders in connection with securities purchase agreements entered into on January 28, 2022 and September 20, 2022. The Company recorded 699,848 shares of common stock that are not exercised but registered in accordance with their common warrant agreements and 500,000 shares of common stock that are not exercised but registered in accordance with their pre-funded warrant agreements upon the filing of this Form S-1/A | | | | | | | | | | | | | | | |
Number of shares grant | shares | 1,000,000 | | | | | | | | | | | | | | | | | | | | | | | |
Number of shares granted fair value | $ 271,000 | | | | | | | | | | | | | | | | | | | | | | | |
Vesting period | The restricted stock grant vests over a period of two years, with 25% of the shares of restricted stock vesting six months after the Peterson Employment Agreement Effective Date, and the remainder vesting in equal tranches on each of the 12-, 18-, and 24-month anniversary dates of the Peterson Employment Agreement | | | | | | | | | | | | | | | | | | | | | | | |
Stock based compensation | | | | | | | | | | | | | | | | | | | | | $ 3,341 | | | |
Warrants expiration term | | | | | | | | | | | | | | | | | | | | 3 years | | | | |
Expected term | | | | | | | | | | | | | | | | | | | | | 5 years | | | |
Expected volatility rate | | | | | | | | | | | | | | | | | | | | | 137.10% | | | |
Expected dividend rate | | | | | | | | | | | | | | | | | | | | | 0% | | | |
Options exercise price | $ / shares | | | | | | | | | | | | | | | | | | | | | $ 1.12 | | | |
New Modified Terms [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Aggregate of warrants | shares | | | 451,831 | | | | | 2,449,466 | | | | | | | | | | | | | | | | |
Original Issue Terms [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Aggregate of warrants | shares | | | 559,878 | | | | | 1,959,573 | | | | | | | | | | | | | | | | |
Measurement Input, Option Volatility [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Warrant measurement input | | | | | | | | | | | | | | | | | | | | 92 | | | | |
Measurement Input, Option Volatility [Member] | New Modified Terms [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Expected volatility rate | | | 148% | | | | | 136% | | | | | | | | | | | | | | | | |
Measurement Input, Option Volatility [Member] | Original Issue Terms [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Expected volatility rate | | | 148% | | | | | 136% | | | | | | | | | | | | | | | | |
Measurement Input, Exercise Price [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Warrant measurement input | | | | | | | | | | | | | | | | | | | | 50 | | | | |
Measurement Input, Exercise Price [Member] | New Modified Terms [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Exercise price | $ / shares | | | $ 0.11 | | | | | $ 0.80 | | | | | | | | | | | | | | | | |
Measurement Input, Exercise Price [Member] | Original Issue Terms [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Exercise price | $ / shares | | | 1.03 | | | | | 1.03 | | | | | | | | | | | | | | | | |
Measurement Input, Share Price [Member] | New Modified Terms [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Share price | $ / shares | | | 0.57 | | | | | 1.53 | | | | | | | | | | | | | | | | |
Measurement Input, Share Price [Member] | Original Issue Terms [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Share price | $ / shares | | | $ 0.57 | | | | | $ 1.43 | | | | | | | | | | | | | | | | |
Measurement Input, Expected Term [Member] | New Modified Terms [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Expected term | | | 3 years | | | | | 3 years | | | | | | | | | | | | | | | | |
Measurement Input, Expected Term [Member] | Original Issue Terms [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Expected term | | | 3 years | | | | | 3 years | | | | | | | | | | | | | | | | |
Measurement Input, Expected Dividend Rate [Member] | New Modified Terms [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Expected dividend rate | | | 0% | | | | | 0% | | | | | | | | | | | | | | | | |
Measurement Input, Expected Dividend Rate [Member] | Original Issue Terms [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Expected dividend rate | | | 0% | | | | | 0% | | | | | | | | | | | | | | | | |
Measurement Input, Discount Rate [Member] | New Modified Terms [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Warrant measurement input | | | 4.82 | | | | | 4.54 | | | | | | | | | | | | | | | | |
Measurement Input, Discount Rate [Member] | Original Issue Terms [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Warrant measurement input | | | 4.82 | | | | | 4.54 | | | | | | | | | | | | | | | | |
2022 Equity Incentive Plan [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Stock based compensation | | | | | | | | | | | | | | | | | | | | | $ 440,219 | 0 | | |
Share based compensation, unrecognized expense | | | | | | | | | | | | | | | | | | | | | 1,064,781 | | | |
Restricted Stock Units (RSUs) [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Issuance of common stock for cash net, shares | shares | | | | | | | | | | | | 700,000 | | | | | | | | | | | | |
Grant date value | | | | | | | | | | | | $ 1,505,000 | | | | | | | | | | | | |
Common stock par value | $ / shares | | | | | | | | | | | | $ 2.15 | | | | | | | | | | | | |
Stock based compensation | | | | | | | | | | | | | | | | | | | | | 96,016 | $ 0 | | |
Share based compensation, unrecognized expense | | | | | | | | | | | | | | | | | | | | | $ 177,259 | | | |
Share-Based Payment Arrangement, Option [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Options exercise price | $ / shares | | | | | | | | | | | | | | | | | | | | | $ 0.52 | | | |
GPL Ventures LLC [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock, par value | $ / shares | | | | | | | | | | | | | | | | | $ 0.0001 | | | | | | | |
Issuance of common stock for cash net, shares | shares | | | | | | | | | | | | | | | | | 4,500,000 | | | | | | | |
Share price | $ / shares | | | | | | | | | | | | | | | | | $ 0.29 | | | | | | | |
Grant date value | | | | | | | | | | | | | | | | | $ 1,322,933 | | | | | | | |
Warrant [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Equity fair value | | | | | | | | | | | | | | | | | | | | $ 994,091 | | | $ 994,091 | |
Issuance of common stock for cash net, shares | shares | | 451,831 | | | | | | | | | | | 100,000 | | | | | | | | | | | |
Share price | $ / shares | | | | | | | | | | | | | $ 3.30 | | | | | | | | | | | |
Warrants expiration term | | | | | | | | | | | | | | | | | | | | 3 years | | | | |
Aggregate of warrants | shares | | | | | | | | | | | | | | | | | | | | 2,519,451 | | | | |
Exercise price of warrants or rights | $ / shares | | | | | | | | $ 0.80 | | | | | | | | | | | | $ 1.03 | | | | |
Warrant exercise price, description | | | (i) reduce the exercise price of the warrant from an exercise price of $1.03 per share to $0.11 per share and (ii) add a customary cashless exercise provision to the warrant. | | | | | i) the exercise price was reduced from $1.03 to $0.80 and ii) the number of warrants was increased by a factor of 1.25 or 489,893 warrants in order to induce full, immediate exercise. | | | | | | | | | | | | | | | | |
Net of equity issuance costs | | | | | | | | $ 146,938 | | | | | | | | | | | | | | | | |
Proceeds from issuance of warrants | | | | | | | | 1,812,635 | | | | | | | | | | | | | | | | |
Warrant [Member] | New Modified Terms [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Net of equity issuance costs | | | $ 1,000 | | | | | $ 300,000 | | | | | | | | | | | | | | | | |
Common Stock [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock, par value | $ / shares | | | | | | | $ 0.0001 | | | $ 0.0001 | $ 0.0001 | | | | | | | | $ 0.0001 | | | | | |
Issuance of common stock for cash net, shares | shares | | | | | | | | | | | | | 12,500 | | | | | | 400,000 | | 400,000 | 10,000 | | |
Grant date value | | | | | | | | | | | | | | | | | | | | | $ 40 | $ 1 | | |
Common stock par value | $ / shares | | | | | | | $ 1.21 | | | $ 0.88 | $ 2.10 | | $ 2 | | | | | | $ 1 | | | | | |
Gross proceeds | | | | | | | | | | | | | | | | | | | $ 400,000 | | | | | |
Stock issued during period for services | shares | | | | | | | 100,000 | | | 100,000 | 25,000 | | | | | | | | | | 285,500 | | | |
Stock issued value during period for services | | | | | | | | | | | | | | | | | | | | | $ 29 | | | |
Common Stock [Member] | Restricted Stock Units (RSUs) [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock, par value | $ / shares | | | | $ 0.0001 | | | | | | | | | | | | | | | | | | | | |
Issuance of common stock for cash net, shares | shares | | | | 425,000 | | | | | | | | | | | | | | | | | | | | |
Grant date value | | | | $ 273,275 | | | | | | | | | | | | | | | | | | | | |
Common stock par value | $ / shares | | | | $ 0.64 | | | | | | | | | | | | | | | | | | | | |
IPO [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Issuance of common stock for cash net, shares | shares | | | | | | | | | | | | | | | | | | 375,000 | | | | | | |
Common stock par value | $ / shares | | | | | | | | | | | | | | | | | | $ 3 | | | | | | |
Gross proceeds | | | | | | | | | | | | | | | | | | $ 6,000,000 | | | | | | |
Number of shares sold | shares | | | | | | | | | | | | | 2,000,000 | | | | | 2,000,000 | | | | | | |
Sale of stock, price per share | $ / shares | | | | | | | | | | | | | $ 3 | | | | | $ 3 | | | | | | |
Percentage of outstanding principal balance | | | | | | | | | | | | | | | | | | 25% | | | | | | |
Debt instrument, principal amount | | | | | | | | | | | | | | | | | | $ 4,500,000 | | | | | | |
Percentage of public offering price | | | | | | | | | | | | | | | | | | | 110% | | | | | |
Two Accredited Investors [Member] | Common Stock [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Number of shares issued | shares | | | | | | | | | | | | | | | | | | | 400,000 | | | | | |
Over-Allotment Option [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Exercise price of warrants or rights | $ / shares | | | | | | | | | | | | | $ 3.30 | | | | | | $ 3.30 | | | | | |
Shares issued warrants to purchase | shares | | | | | | | | | | | | | 100,000 | | | | | | 100,000 | | | | | |
Percentage of public offering price | | | | | | | | | | | | | 110% | | | | | | | | | | | |
Investors [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock par value | $ / shares | | | | | | | | | | | | | | $ 0.29 | | | | | | | | | $ 0.29 | |
Investors [Member] | IPO [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock par value | $ / shares | | | | | | | | | | | | | | | | | | | | | | | $ 3 | |
Debt instrument, principal amount | | | | | | | | | | | | | | | | | | | | | | | $ 4,500,000 | |
Investors [Member] | IPO [Member] | Warrant [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Warrant exercisable, rate | | | | | | | | | | | | | | | | | | | | 50 | | | | |
Director [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Stock based compensation | | | | | | | | | | | | | | | | $ 50,000 | | | | | | | | |
Director [Member] | Restricted Stock Units (RSUs) [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Issuance of common stock for cash net, shares | shares | | | | | | | | | | | | | | | 60,000 | | | | | | | | | |
Share price | $ / shares | | | | | | | | | | | | | | | $ 0.29 | $ 0.29 | | | | | | | | |
Grant date value | | | | | | | | | | | | | | | $ 300,000 | | | | | | | | | |
Common stock par value | $ / shares | | | | | | | | | | | | | | | $ 0.0001 | $ 0.0001 | | | | | | | | |
Total fair value | | | | | | | | | | | | | | | $ 88,200 | | | | | | | | | |
Stock based compensation | | | | | | | | | | | | | | | | | | | | | 88,200 | $ 0 | | |
Share based compensation, unrecognized expense | | | | | | | | | | | | | | | | | | | | | 0 | | | |
Executives [Member] | Restricted Stock [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Issuance of common stock for cash net, shares | shares | | | | | | | | | | | | | | 1,100,000 | | | | | | | | 1,100,000 | | |
Grant date value | | | | | | | | | | | | | | | | | | | | | | $ 323,400 | | |
Stock based compensation | | | | | | | | | | | | | | | | | | | | | 161,700 | 6,202 | | |
Share based compensation, unrecognized expense | | | | | | | | | | | | | | | | | | | | | 155,498 | | | |
Consultants [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Stock based compensation | | | | | | | | | | | | | $ 25,000 | | | | | | | | | | | |
Stock issued value during period for services | | | | | | | $ 121,000 | | | $ 88,000 | $ 52,500 | | | | | | | | | | | | | |
Marcum LLP [Member] | Common Stock [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock, par value | $ / shares | | | | | | | | | $ 0.0001 | | | | | | | | | | | | | | | |
Issuance of common stock for cash net, shares | shares | | | | | | | | | 48,000 | | | | | | | | | | | | | | | |
Grant date value | | | | | | | | | $ 80,159 | | | | | | | | | | | | | | | |
Common stock par value | $ / shares | | | | | | | | | $ 1.67 | | | | | | | | | | | | | | | |
Mr Frank Ingriselli [Member] | Restricted Stock Units (RSUs) [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Issuance of common stock for cash net, shares | shares | | | | | | 200,000 | | | | | | | | | | | | | | | | | | |
Grant date value | | | | | | $ 213,000 | | | | | | | | | | | | | | | | | | |
Common stock par value | $ / shares | | | | | | $ 1.07 | | | | | | | | | | | | | | | | | | |
Four Outside Director [Member] | Restricted Stock Units (RSUs) [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Issuance of common stock for cash net, shares | shares | | | | 425,000 | | | | | | | | | | | | | | | | | | | | |
Share price | $ / shares | | | | $ 0.64 | | | | | | | | | | | | | | | | | | | | |
Grant date value | | | | $ 273,275 | | | | | | | | | | | | | | | | | | | | |
Common stock par value | $ / shares | | | | $ 0.0001 | | | | | | | | | | | | | | | | | | | | |
Stock based compensation | | | | | | | | | | | | | | | | | | | | | 96,016 | $ 0 | | |
Share based compensation, unrecognized expense | | | | | | | | | | | | | | | | | | | | | $ 177,259 | | | |
Consultant [Member] | Share-Based Payment Arrangement, Option [Member] | | | | | | | | | | | | | | | | | | | | | | | | |
Subsidiary, Sale of Stock [Line Items] | | | | | | | | | | | | | | | | | | | | | | | | |
Number of shares issued | shares | | | | | 120,000 | | | | | | | | | | | | | | | | | | | |
Options exercise price | $ / shares | | | | | $ 0.52 | | | | | | | | | | | | | | | | | | | |
Number of options vesting period | | | | | 24 months | | | | | | | | | | | | | | | | | | | |
Number of options granted fair value | | | | | $ 55,711 | | | | | | | | | | | | | | | | | | | |